Neonatal screening for developmental dysplasia of the hip on the maternity wards in Crete, Greece. correlation to

C Giannakopoulou1, A Aligizakis, E Korakaki

  • 1Department of Neonatology, University of Crete, Greece.

Insights

This study found that developmental dysplasia of the hip (DDH) occurs in 10.83 per 1,000 newborns in Crete. Ultrasound screening for infants with risk factors or clinical hip abnormalities aids early detection and improves treatment outcomes.

Area of Science:

  • Pediatrics
  • Orthopedics
  • Medical Imaging

Background:

  • Developmental dysplasia of the hip (DDH) is a condition requiring early detection.
  • Risk factors and clinical examination are crucial for identifying infants with hip instability.

Purpose of the Study:

  • To evaluate ultrasound's effectiveness in detecting and managing DDH in newborns.
  • To investigate the incidence of DDH in Crete and its correlation with risk factors.

Main Methods:

  • A cohort of 6,140 newborns underwent standard assessments and physical examinations.
  • Ultrasonography using the Graf technique was performed on high-risk infants or those with clinical suspicion of DDH.
  • Treatment was guided by the Graf classification.

Main Results:

  • Ultrasound was performed on 3.58% of newborns, identifying DDH in 10.83 per 1,000 infants.
  • Pathological hip sonography findings were present in 32.30% of neonates with risk factors but normal clinical exams.

Conclusions:

  • The incidence of DDH in Crete is estimated at 10.83 per 1,000, higher than in other parts of Greece.
  • Selective ultrasonography is a valuable adjunctive tool for early DDH diagnosis in at-risk infants.
  • Early diagnosis and targeted treatment improve management control for DDH.
Abstract

Related Concept Videos